Real-Time
Market Intelligence

LOS ANGELES, Oct. 8, 2025 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ:PRTS), a leading e-commerce provider of automotive parts and accessories, today announced board transitions following its recently completed strategic investment from ZongTeng Group, a world-class distribution and logistics powerhouse, A-Premium, a recognized global leader in mechanical parts procurement, marketing and e-commerce, and CDH Investments, a highly respected asset manager. In connection with the strategic investment, Henry Maier and James Barnes have decided to step down from the Company's Board o

ENCINO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (NASDAQ:NTWK), a provider of AI-powered solutions and services enabling OEMs, dealerships and financial institutions to sell, finance and lease assets, announced the launch of Check AI – its next-generation AI-powered credit decisioning engine designed to revolutionize the credit underwriting process. Built as an AI-native solution and part of the company's Transcend Finance platform, Check AI streamlines and enhances the credit evaluation lifecycle by automating manual tasks, accelerating decision times and improving underwriting accuracy. From gathering data across multiple sources to processing documents and pe

MENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate long-read sequencing solutions, today announced that the National Institute on Aging's Long Life Family Study (LLFS) selected PacBio technology to generate comprehensive genomic and epigenomic data from as many as 7,800 participants. The effort will employ PacBio's Revio systems to capture highly accurate HiFi long-read sequencing data designed to shed light on why longevity runs in families and what drives healthier aging. "Long-read HiFi sequencing gives us the accuracy and resolution to see variants and methylation patterns missed by other technologies," said

Netanya, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE:SYNX) ("Silynxcom" or the "Company"), a manufacturer and developer of ruggedized tactical communication headset devices, today announced it has received a $935,000 purchase order for its cutting-edge in-ear tactical headset systems. The deployment will equip field personnel with enhanced communication capabilities, enabling faster response times and reduced risk during complex scenarios. The selected Silynxcom in-ear systems, including the award-winning Clarus and C4 series, deliver superior hearing protection with active noise cancellation, ensuring operators are safeguarded from hazardous noise levels, while allowi

Morgan Stanley reiterated coverage of e.l.f. Beauty with a rating of Overweight and set a new price target of $170.00 from $134.00 previously

UBS upgraded MFA Financial from Neutral to Buy and set a new price target of $10.50

TD Securities upgraded First Majestic Silver from Hold to Buy

UBS reiterated coverage of Monster Beverage with a rating of Neutral and set a new price target of $72.00 from $67.00 previously

4 - DLH Holdings Corp. (0000785557) (Issuer)

4 - Scholar Rock Holding Corp (0001727196) (Issuer)

4 - VAIL RESORTS INC (0000812011) (Issuer)

4 - Mueller Water Products, Inc. (0001350593) (Issuer)

4 - FLEXSTEEL INDUSTRIES INC (0000037472) (Issuer)

4 - DLH Holdings Corp. (0000785557) (Issuer)

4 - UNITED NATURAL FOODS INC (0001020859) (Issuer)

4 - UNITED NATURAL FOODS INC (0001020859) (Issuer)

6-K - Copa Holdings, S.A. (0001345105) (Filer)

6-K - Collective Mining Ltd. (0001953575) (Filer)

8-K - N2OFF, Inc. (0001789192) (Filer)

8-K - NB Bancorp, Inc. (0001979330) (Filer)

For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

Award-Winning Senior Marketing Leader Joins High-Growth Specialty Casual Dining Company DALLAS, Texas, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Twin Hospitality Group Inc. ("Twin Hospitality") (NASDAQ:TWNP), the parent company of Twin Peaks and Smokey Bones, today announced the appointment of Melissa Fry as Chief Marketing Officer, effective immediately. Fry brings over 25 years of proven marketing expertise across the restaurant and hospitality industries, most recently serving as Senior Director of Marketing for Hooters of America, where she played a key role in elevating the brand's global presence. Since joining Twin Hospitality Group in May, CEO Kim Boerema has strategically strengthened t

BIRMINGHAM, Ala., Oct. 8, 2025 /PRNewswire/ -- 1919 Investment Counsel, LLC ("1919"), a subsidiary of Stifel Financial Corp. ("Stifel"), is pleased to announce the hiring of Braxton Comer as a Principal, Business Development Officer. Braxton brings a dynamic blend of strategic insight and legal expertise to the firm. He began his career at Accenture LLP in Atlanta, where he focused on delivering strategic solutions for a global client base. Following his time in consulting, Braxton earned his law degree from The University of Alabama School of Law and went on to establish a successful solo practice in Alabama, advising family offices and non-profit organizations with a deep understanding of

SPAR Group ("SGRP" or the "Company"), an innovative services company offering comprehensive merchandising, marketing and distribution solutions to retailers and brands across North America, today announces strategic and leadership advancements. Commencing a new chapter for SPAR Group, management anticipates outperforming key financial metrics in 2026, following nearly two years of strategic alternatives work, the divestment of offshore businesses and the repositioning of its operations. The Company recently named William Linnane as President, based on his demonstrated strategic leadership. Linnane has consistently delivered robust revenue goals while driving a strong sales pipeline across t

- Bitcoin treasury as of September 30, 2025 valued at $34.7 million or $2.24 per share1 TAMPA, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ:LMFA) ("LM Funding" or the "Company"), a Bitcoin treasury and mining company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month ended September 30, 2025. MetricAugust 2025September 2025- Bitcoin2  - Mined, net5.85.9- Sold(9.0)(12.5)- Purchased164-- Service Fee-(0.1)- Bitcoin HODL311.2304.5- Machines2  - Oklahoma4,3204,320- Mississippi-2,376- Storage1,218795- Total Machines5,5387,491- Hashrate (EH/s2)  - Oklahoma0.480.48- Mississippi3-0.22- Energized0.480.70- Monthly Average0.390

VAN BUREN TOWNSHIP, Mich., Oct. 8, 2025 /PRNewswire/ -- Visteon Corporation (NASDAQ:VC), a global leader in automotive cockpit electronics, will release its third quarter 2025 financial results before the market opens on Thursday, October 23. The company will host a conference call for the investment community at 9 a.m. ET to discuss the results and related matters. The conference call is also available to the public via live audio webcast. The dial-in numbers to participate in the call are: U.S./Canada Participants Toll-Free Dial-In Number: 1-888-330-2508International Partici

CHARLOTTE, N.C., Oct. 8, 2025 /PRNewswire/ -- As previously announced, Bank of America will report its third quarter 2025 financial results on Wednesday, October 15. The results will be released at approximately 6:45 a.m. ET, followed by an investor conference call at 8:30 a.m. ET. The news release, supplemental filing and investor presentation can be accessed at Bank of America's Investor Relations website at https://investor.bankofamerica.com/quarterly-earnings. A Form 8-K containing Bank of America's financial results will also be available at the U.S. Securities and Exchan

MONTEVIDEO, Uruguay, Oct. 08, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ:DLO, "dLocal" or the "Company")), a technology-first payments platform enabling global enterprise merchants to connect with billions of consumers in emerging markets, intends to release financial results for its third fiscal quarter ended September 30, 2025 on November 12, 2025 after market close. The Company will host a conference call and video webcast on November 12, 2025 at 5:00 p.m. Eastern Time. Please click here to pre-register for the conference call and obtain your dial in number and passcode. The live conference call can be also accessed via audio webcast at the investor relations section of the Compa

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2025 results on Wed., Nov. 5, 2025, at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its third-quarter 2025 results prior to the call. The audiocast will be accessible at www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial +1 833 470 1428 (if dialing from within the U.S.) or +1 929 526 1599 (if dialing from outside the U.S.). The conference call access code is 817099. A replay will be available on th

SC 13D/A - ALLIANCEBERNSTEIN HOLDING L.P. (0000825313) (Subject)

SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

SC 13D/A - INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ (0000949961) (Subject)

SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

Recently, on July 4, 2024, a significant insider purchase was recorded at Allied Gaming & Entertainment Inc. as Large owner Choi Roy bought $456,750 worth of shares (360,000 units at $1.27), increasing direct ownership by 14% to 2,871,822 units (SEC Form 4). This purchase is notable for the size of the transaction and the percentage increase in direct ownership, indicating a strong belief in the company's future prospects. Insider purchases are generally viewed positively by investors as they signal confidence from those with intimate knowledge of the company's operations. Examining other recent insider transactions at Allied Gaming & Entertainment Inc., we notice a few patterns worth explo

Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan